"New Perspectives on Cardioembolic Stroke”
Karen Furie, MD, MPH
Karen Furie, MD, MPH is Chief of Neurology at Rhode Island Hospital, The Miriam Hospital and Bradley Hospital, and serves as Professor and Chair of the Department of Neurology at The Warren Alpert Medical School of Brown University and co-director of the Norman Prince Neurosciences Institute. She was the principal investigator of the NINDS P50 Partners Specialized Program of Translational Research in Acute Stroke (SPOTRIAS) and the American Heart Association supported Harvard Bugher Center for Stroke Prevention and Genetics Research while at MGH. Dr. Furie has been involved in organizing and executing clinical trials dating back to the Trial or Org 10172 in acute stroke (TOAST). She was a co-investigator in the Enlimomab, CAPRIE, WARSS, VISP, WARCEF, MATCH, PRoFESS, and IRIS trials. In addition, Dr. Furie served as Chair of the NSDK and ANIE study sections, co-Chair of NST-1 and on the DSMB’s of WASID, SPS3, ARUBA, StrokeNet, CREST-2, and SIREN. Dr. Furie’s interest in biomarkers is broad. She has studied vitamins and homocysteine, inflammatory biomarkers, markers of oxidative stress and coagulation, genetics/genomics, and multimodal imaging. She served as faculty in the NINDS Clinical Trials course, and early research career leadership courses run by the American Heart Association and American Neurological Association in partnership with NINDS and as a mentor in the TRANSCENDS (Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars) Scholars program funded by NIH. Dr. Furie is past-Chair of Stroke Council and was Deputy Editor of the journals Stroke and JNNP. She currently serves as a member of the AHA Council of Chairs, the AHA National Research Committee, and is Chair of the Stroke Council nominations committee. She is a member of the Brain Health Science Subcommittee.
